Página principal > Resultados de la búsqueda: Campbell, Stephen
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
11 p, 1.1 MB Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs / Godman, Brian (University of Strathclyde) ; Malmström, Rickard E. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Diogène Fadini, Eduard (Hospital Universitari Vall d'Hebron) ; Jayathissa, Sisira (Hutt Valley DHB. Department of Medicine) ; McTaggart, Stuart (NHS National Services Scotland) ; Cars, Thomas (Uppsala University. Department of Medical Sciences) ; Alvarez-Madrazo, Samantha (University of Strathclyde) ; Baumgärtel, Christoph (Austrian Medicines and Medical Devices Agency) ; Brzezinska, Anna (Agency for Health Technology Assessment) ; Bucsics, Anna (Hauptverband der Österreichischen Sozialversicherungsträger) ; Campbell, Stephen (University of Manchester. Centre for Primary Care) ; Eriksson, Irene (Stockholm County Council. Department of Healthcare Development) ; Finlayson, Alexander (University of Oxford. Green Templeton College) ; Fürst, Jurij (Health Insurance Institute) ; Garuoliene, Kristina (National Health Insurance Fund) ; Gutiérrez-Ibarluzea, Iñaki (Osasun Saila. Ezagutu Osteba arloa) ; Hviding, Krystyna (Norwegian Medicines Agency) ; Herholz, Harald (Kassenärztliche Vereinigung Hessen) ; Joppi, Roberta (Azienda Sanitaria Locale of Verona. Pharmaceutical Drug Department) ; Kalaba, Marija (Republic Institute for Health. Department of Medicines and Pharmacoeconomics) ; Laius, Ott (State Agency of Medicines) ; Malinowska, Kamila (National Health Fund. Drug Management Department) ; Pedersen, Hanne B. (Division of Health Systems and Public Health, Health Technologies and Pharmaceuticals, WHO Regional Office for Europe) ; Markovic-Pekovic, Vanda (Ministry of Health and Social Welfare) ; Piessnegger, Jutta (Hauptverband der Österreichischen Sozialversicherungsträger) ; Selke, Gisbert (Wissenschaftliches Institut der AOK (WidO)) ; Sermet, Catherine (IRDES) ; Spillane, Susan (Trinity College. Department of Pharmacology and Therapeutics) ; Tomek, Dominik (Slovak Medical University. Faculty of Pharmacy) ; Vončina, Luka (Ministry of Health) ; Vlahović-Palčevski, Vera (University Hospital Rijeka. Unit for Clinical Pharmacology) ; Wale, Janet (Independent Consumer Advocate, VIC) ; Wladysiuk, Magdalena (HTA Consulting) ; van Woerkom, Menno (Dutch Institute for Rational Use of Medicine) ; Zara, Corinne (Institut Català de la Salut) ; Gustafsson, Lars L. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Universitat Autònoma de Barcelona
Background : There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are effectiveness, safety and/or budget concerns. Dabigatran, a new oral anticoagulant for the prevention of stroke in patients with non-valvular atrial fibrillation (AF), exemplifies this issue. [...]
2014 - 10.3389/fphar.2014.00109
Frontiers in Pharmacology, Vol. 5 (june 2014)  
Registro completo - Creative Commons
2.
9 p, 189.2 KB Cardiovascular risk management in patients with coronary heart disease in primary care : variation across countries and practices. An observational study based on quality indicators / van Lieshout, Jan (Radboud University Nijmegen Medical Centre. Scientific Institute for Quality of Health Care (Nijmegen, Països Baixos)) ; Grol, Richard (Radboud University Nijmegen Medical Centre. Scientific Institute for Quality of Health Care (Nijmegen, Països Baixos)) ; Campbell, Stephen (University of Manchester. Health Sciences - Primary Care Research Group (Manchester, Regne Unit)) ; Falcoff, Hector (Université Paris Descartes. Département de Médecine Générale) ; Frigola-Capell, Eva (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ; Glehr, Mathias (Medical University of Graz. Department of Orthopedic Surgery (Graz, Àustria)) ; Goldfracht, Margalit (Clalit Health Services (Tel Aviv, Israel)) ; Kumpusalo, Esko (University of Eastern Finland, Department of Public Health and General Practice (Kuopio, Finlàndia)) ; Künzi, Beat (Swisspep Institut für Qualität und Forschung im Gesundheitswesen (Berna, Suïssa)) ; Ludt, Sabine (University of Heidelberg. Department of General Practice and Health Services Research (Heildelberg, Alemanya)) ; Petek, Davorina (Zdravje Medical Center (Ljubljana, Eslovènia)) ; Vanderstighelen, Veerle (Domus Medica (Berchem, Bèlgica)) ; Wensing, Michel (Radboud University Nijmegen Medical Centre. Scientific Institute for Quality of Health Care (Nijmegen, Països Baixos))
Background: Primary care has an important role in cardiovascular risk management (CVRM) and a minimum size of scale of primary care practices may be needed for efficient delivery of CVRM . We examined CVRM in patients with coronary heart disease (CHD) in primary care and explored the impact of practice size. [...]
2012 - 10.1186/1471-2296-13-96
BMC family practice, Vol. 13, N. 96 (October 2012) , p. 1-9  
Registro completo - Creative Commons

Vea también: autores con nombres similares
1 Campbell, Suzanne
3 Campbell, Sydney
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos